Lisa LeCointe-Cephas

Insider Reports History

Location
Kenilworth, NJ
Signature
/s/ Kelly E. W. Grez as attorney-in-fact for Lisa LeCointe-Cephas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lisa LeCointe-Cephas:

Company Role Class Num Shares Value Price $ Report Date Ownership
Merck & Co., Inc. SVP Chief Ethics & Com Officer Common Stock 5,142 $614,072 $119.43 04 May 2023 Direct
Merck & Co., Inc. SVP Chief Ethics & Com Officer Restricted Stock Unit 816 $105,101 $128.80 04 May 2023 Direct
Merck & Co., Inc. SVP Chief Ethics & Com Officer Stock Option (Right to Buy) 9,682 02 May 2023 Direct

Insider Reports Filed by Lisa LeCointe-Cephas

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MRK Merck & Co., Inc. 03 May 2023 6 +$116,534 4 SVP Chief Ethics & Com Officer 05 May 2023, 17:01
MRK Merck & Co., Inc. 02 May 2023 2 $0 4 SVP Chief Ethics & Com Officer 04 May 2023, 18:37
MRK Merck & Co., Inc. 01 May 2023 3 +$48,728 4 SVP Chief Ethics & Com Officer 03 May 2023, 15:11
MRK Merck & Co., Inc. 03 May 2022 5 +$46,511 4 SVP Chief Ethics & Com Officer 05 May 2022, 17:04
MRK Merck & Co., Inc. 03 May 2022 3 +$26,032 4 SVP Chief Ethics & Com Officer 04 May 2022, 17:58
MRK Merck & Co., Inc. 01 May 2022 3 +$37,250 4 SVP Chief Ethics & Com Officer 03 May 2022, 16:25